A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) for gemcitabine.
- DOI
- 10.1080/14740338.2024.2419999
- Published
- 2025 Mar
- Container
- Expert opinion on drug safety
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/14740338.2024.2419999,
title = {A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) for gemcitabine.},
author = {Zhang C and Li K and Xu SN and Qiao L and Ren YL and Li Q and Liu Y},
year = {2025},
journal = {Expert opinion on drug safety},
doi = {10.1080/14740338.2024.2419999},
url = {https://doi.org/10.1080/14740338.2024.2419999}
}RIS
TY - JOUR TI - A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) for gemcitabine. AU - Zhang C AU - Li K AU - Xu SN AU - Qiao L AU - Ren YL AU - Li Q AU - Liu Y PY - 2025 JO - Expert opinion on drug safety DO - 10.1080/14740338.2024.2419999 UR - https://doi.org/10.1080/14740338.2024.2419999 ER -
APA
C, Z., K, L., SN, X., L, Q., YL, R., Q, L., & Y, L. (2025). A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) for gemcitabine.. Expert opinion on drug safety. https://doi.org/10.1080/14740338.2024.2419999
Source records
- pubmed · retrieved 2026-09-26T01:32:54.495Z